Cargando…

P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.

Detalles Bibliográficos
Autores principales: Guo, Yuelu, Hu, Kai, Ke, Xiaoyan, Xu, Teng, Feng, Shaomei, Zheng, Peihao, MA, Lixia, Yang, Fan, Shi, Hui, Deng, Biping, Rui, Liu, Fu, Zhonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430905/
http://dx.doi.org/10.1097/01.HS9.0000971676.94450.1b
_version_ 1785091071565365248
author Guo, Yuelu
Hu, Kai
Ke, Xiaoyan
Xu, Teng
Feng, Shaomei
Zheng, Peihao
MA, Lixia
Yang, Fan
Shi, Hui
Deng, Biping
Rui, Liu
Fu, Zhonghua
author_facet Guo, Yuelu
Hu, Kai
Ke, Xiaoyan
Xu, Teng
Feng, Shaomei
Zheng, Peihao
MA, Lixia
Yang, Fan
Shi, Hui
Deng, Biping
Rui, Liu
Fu, Zhonghua
author_sort Guo, Yuelu
collection PubMed
description
format Online
Article
Text
id pubmed-10430905
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104309052023-08-17 P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. Guo, Yuelu Hu, Kai Ke, Xiaoyan Xu, Teng Feng, Shaomei Zheng, Peihao MA, Lixia Yang, Fan Shi, Hui Deng, Biping Rui, Liu Fu, Zhonghua Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430905/ http://dx.doi.org/10.1097/01.HS9.0000971676.94450.1b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Guo, Yuelu
Hu, Kai
Ke, Xiaoyan
Xu, Teng
Feng, Shaomei
Zheng, Peihao
MA, Lixia
Yang, Fan
Shi, Hui
Deng, Biping
Rui, Liu
Fu, Zhonghua
P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.
title P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.
title_full P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.
title_fullStr P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.
title_full_unstemmed P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.
title_short P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.
title_sort p1195: a prospective study of targeted sequential immunotherapy. in patients with relapsed refractory primary mediastinal large b-cell lymphoma.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430905/
http://dx.doi.org/10.1097/01.HS9.0000971676.94450.1b
work_keys_str_mv AT guoyuelu p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT hukai p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT kexiaoyan p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT xuteng p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT fengshaomei p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT zhengpeihao p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT malixia p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT yangfan p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT shihui p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT dengbiping p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT ruiliu p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT fuzhonghua p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma